Marinus Pharmaceuticals Overview
Marinus Pharmaceuticals Discounted Cash Flow
DCF Analysis for MRNS.
Get informed when a big investor buys or sells
+ FollowFair Value
$12.31
Current Fair Value
$12.31
↑ 2137.8% Upside
Undervalued by 2137.8% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison